Developmental variability channels mouse molar evolution

  1. Luke Hayden
  2. Katerina Lochovska
  3. Marie Sémon
  4. Sabrina Renaud
  5. Marie-Laure Delignette-Muller
  6. Maurine Vilcot
  7. Renata Peterkova
  8. Maria Hovorakova  Is a corresponding author
  9. Sophie Pantalacci  Is a corresponding author
  1. ENS de Lyon, France
  2. Charles University, Czech Republic
  3. Université Lyon 1, CNRS, VetAgro Sup, UMR 5558, France
  4. The Czech Academy of Sciences, Czech Republic

Abstract

Do developmental systems preferentially produce certain types of variation that orient phenotypic evolution along preferred directions? At different scales, from the intra-population to the interspecific, the murine first upper molar shows repeated anterior elongation. Using a novel quantitative approach to compare the development of two mouse strains with short or long molars, we identified temporal, spatial and functional differences in tooth signaling center activity, that arise from differential tuning of the activation-inhibition mechanisms underlying tooth patterning. By tracing their fate, we could explain why only the upper first molar reacts via elongation of its anterior part. Despite a lack of genetic variation, individuals of the elongated strain varied in tooth length and the temporal dynamics of their signaling centers, highlighting the intrinsic instability of the upper molar developmental system. Collectively, these results reveal the variational properties of murine molar development that drive morphological evolution along a line of least resistance.

Data availability

- Sequencing data have been deposited in GEO under accession codes GSE135432.- All data generated or analyzed during this study are included in the manuscript and supporting files. Sources and codes are available on githubhttps://github.com/msemon/cdpchttps://github.com/luke-hayden/dvpap/devstatehttps://github.com/luke-hayden/dvpap/devmorph

The following data sets were generated

Article and author information

Author details

  1. Luke Hayden

    Laboratoire de Biologie et Modélisation de la Cellule, ENS de Lyon, Lyon, France
    Competing interests
    The authors declare that no competing interests exist.
  2. Katerina Lochovska

    1st Department of Medicine, First Faculty of Medicine, Charles University, Prague, Czech Republic
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-4142-4531
  3. Marie Sémon

    Laboratoire de Biologie et Modélisation de la Cellule, ENS de Lyon, Lyon, France
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-3479-7524
  4. Sabrina Renaud

    Laboratoire de Biométrie et Biologie Evolutive, Université Lyon 1, CNRS, VetAgro Sup, UMR 5558, Villeurbanne, France
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-8730-3113
  5. Marie-Laure Delignette-Muller

    Laboratoire de Biométrie et Biologie Évolutive, Université Lyon 1, CNRS, VetAgro Sup, UMR 5558, Villeurbanne, France
    Competing interests
    The authors declare that no competing interests exist.
  6. Maurine Vilcot

    Laboratoire de Biologie et Modélisation de la Cellule, ENS de Lyon, Lyon, France
    Competing interests
    The authors declare that no competing interests exist.
  7. Renata Peterkova

    Department of Histology and Embryology, Third Faculty of Medicine, Charles University, Prague, Czech Republic
    Competing interests
    The authors declare that no competing interests exist.
  8. Maria Hovorakova

    Department of Developmental Biology, Institute of Experimental Medicine, The Czech Academy of Sciences, Prague, Czech Republic
    For correspondence
    maria.hovorakova@iem.cas.cz
    Competing interests
    The authors declare that no competing interests exist.
  9. Sophie Pantalacci

    Laboratoire de Biologie et Modélisation de la Cellule, ENS de Lyon, Lyon, France
    For correspondence
    sophie.pantalacci@ens-lyon.fr
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-0771-8985

Funding

Agence Nationale de la Recherche (ANR-11-BSV7-008)

  • Sophie Pantalacci

Agence Nationale de la Recherche (ANR-11-BSV7-008)

  • Sabrina Renaud

Fondation pour la Recherche Médicale (SPF20140129165)

  • Luke Hayden

Grant Agency of the Czech Republic (14-37368G)

  • Renata Peterkova

Czech Ministry of Education, Youth and Sports (8J19FR032)

  • Maria Hovorakova

Grant Agency of the Czech Republic (18-04859S)

  • Maria Hovorakova

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Ethics

Animal experimentation: This study was performed in a strict accordance with European guidelines (2010/63/UE). It was approved by the CECCAPP Animal Experimentation Ethics Committee (Lyon, France; reference ENS_2014_022), by the Professional committee for guarantee of good life-conditions of experimental animals at the Institute of Experimental Medicine IEM CAS, Prague, Czech Republic) and by the Expert Committee at the Czech Academy of Sciences (permit number: 027/ 2011).

Copyright

© 2020, Hayden et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 1,794
    views
  • 285
    downloads
  • 14
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Luke Hayden
  2. Katerina Lochovska
  3. Marie Sémon
  4. Sabrina Renaud
  5. Marie-Laure Delignette-Muller
  6. Maurine Vilcot
  7. Renata Peterkova
  8. Maria Hovorakova
  9. Sophie Pantalacci
(2020)
Developmental variability channels mouse molar evolution
eLife 9:e50103.
https://doi.org/10.7554/eLife.50103

Share this article

https://doi.org/10.7554/eLife.50103

Further reading

    1. Developmental Biology
    2. Genetics and Genomics
    Svanhild Nornes, Susann Bruche ... Sarah De Val
    Research Article

    The establishment and growth of the arterial endothelium requires the coordinated expression of numerous genes. However, regulation of this process is not yet fully understood. Here, we combined in silico analysis with transgenic mice and zebrafish models to characterize arterial-specific enhancers associated with eight key arterial identity genes (Acvrl1/Alk1, Cxcr4, Cxcl12, Efnb2, Gja4/Cx37, Gja5/Cx40, Nrp1 and Unc5b). Next, to elucidate the regulatory pathways upstream of arterial gene transcription, we investigated the transcription factors binding each arterial enhancer compared to a similar assessment of non-arterial endothelial enhancers. These results found that binding of SOXF and ETS factors was a common occurrence at both arterial and pan-endothelial enhancers, suggesting neither are sufficient to direct arterial specificity. Conversely, FOX motifs independent of ETS motifs were over-represented at arterial enhancers. Further, MEF2 and RBPJ binding was enriched but not ubiquitous at arterial enhancers, potentially linked to specific patterns of behaviour within the arterial endothelium. Lastly, there was no shared or arterial-specific signature for WNT-associated TCF/LEF, TGFβ/BMP-associated SMAD1/5 and SMAD2/3, shear stress-associated KLF4 or venous-enriched NR2F2. This cohort of well characterized and in vivo-verified enhancers can now provide a platform for future studies into the interaction of different transcriptional and signalling pathways with arterial gene expression.

    1. Developmental Biology
    2. Genetics and Genomics
    Anne-Sophie Pepin, Patrycja A Jazwiec ... Sarah Kimmins
    Research Article Updated

    Paternal obesity has been implicated in adult-onset metabolic disease in offspring. However, the molecular mechanisms driving these paternal effects and the developmental processes involved remain poorly understood. One underexplored possibility is the role of paternally induced effects on placenta development and function. To address this, we investigated paternal high-fat diet-induced obesity in relation to sperm histone H3 lysine 4 tri-methylation signatures, the placenta transcriptome, and cellular composition. C57BL6/J male mice were fed either a control or high-fat diet for 10 weeks beginning at 6 weeks of age. Males were timed-mated with control-fed C57BL6/J females to generate pregnancies, followed by collection of sperm, and placentas at embryonic day (E)14.5. Chromatin immunoprecipitation targeting histone H3 lysine 4 tri-methylation (H3K4me3) followed by sequencing (ChIP-seq) was performed on sperm to define obesity-associated changes in enrichment. Paternal obesity corresponded with altered sperm H3K4me3 at promoters of genes involved in metabolism and development. Notably, altered sperm H3K4me3 was also localized at placental enhancers. Bulk RNA-sequencing on placentas revealed paternal obesity-associated sex-specific changes in expression of genes involved in hypoxic processes such as angiogenesis, nutrient transport, and imprinted genes, with a subset of de-regulated genes showing changes in H3K4me3 in sperm at corresponding promoters. Paternal obesity was also linked to impaired placenta development; specifically, a deconvolution analysis revealed altered trophoblast cell lineage specification. These findings implicate paternal obesity effects on placenta development and function as one potential developmental route to offspring metabolic disease.